PhenomeX to Participate in Antibody Engineering & Therapeutics Europe 2023

Company to feature its recently launched Beacon Select™ technology for antibody discovery and cell line development EMERYVILLE, Calif., June 5, 2023 /PRNewswire/ — PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced its participation in the Antibody…

Advertisement — Advertise with Biotech Networks